Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06754514 · ClinicalTrials.gov registry record
Organ Retractor Device Study
A clinical trial of Liver Retraction During Bariatric Surgery, sponsored by Boehringer Labs.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06754514: Recruiting study of Liver Retraction During Bariatric Surgery, sponsored by Boehringer Labs.
NCT06754514 is a study of Liver Retraction During Bariatric Surgery that is actively recruiting participants, run by Boehringer Labs. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06754514, a study of Liver Retraction During Bariatric Surgery, is actively recruiting participants, sponsored by Boehringer Labs.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.
Primary Outcome
After surgery, surgeons will be asked a series of questions and asked to rank the ease of use on a scale of 1-10
Conditions Studied
Interventions
- DEVICE liver retraction
Study Locations (1)
North Carolina
- WakeMed Health & Hospitals - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-03-14 |
| Est. Completion | 2025-01 |
What NCT06754514 shows while recruiting
NCT06754514 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Liver Retraction During Bariatric Surgery appearing as the primary indexed condition, and to 1 intervention - of which liver retraction is the first listed.
NCT06754514 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06754514 about?
NCT06754514 is a clinical study titled "Organ Retractor Device Study". This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.
What is the current status of trial NCT06754514?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-03-14. Estimated completion is 2025-01.
What conditions does trial NCT06754514 study?
This clinical trial studies the following conditions: Liver Retraction During Bariatric Surgery.
What interventions are being tested in trial NCT06754514?
The interventions under investigation include: liver retraction (DEVICE).
Who is sponsoring clinical trial NCT06754514?
This trial is sponsored by Boehringer Labs, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06754514 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI